ABBOTINDIA

ABBOTT INDIA

Large Cap BSE: 500488 NSE: ABBOTINDIA
₹20100.00
-82.9 (-0.41%)
  • Advice
  • Hold
As on 05 December, 2022 | 16:28

Abbott India Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in ABBOTT INDIA

Start SIP

Abbott India Share Price

Abbott India Share Returns

  • Over 1 Month 2.5%
  • Over 3 Month 8.99%
  • Over 6 Month 9.38%
  • Over 1 Year 5.76%

Abbott India Key Statistics

P/E Ratio 48.4
PEG Ratio 2.1
Market Cap Cr 42,711
Price to Book Ratio 15.1
EPS 375.9
Dividend 1.4
Relative Strength Index 59.8
Money Flow Index 71.3
MACD Signal 334.09
Average True Range 407.09

Abbott India Investment Rating

  • Master Rating:
  • Abbott India has an operating revenue of Rs. 5,163.23 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 22% is great, ROE of 28% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 10% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 76 which is a FAIR score but needs to improve its earnings, a RS Rating of 56 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Abbott India Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1,3791,3041,2551,2241,2221,2181,096
Operating Expenses Qtr Cr 1,0361,034961955962953890
Operating Profit Qtr Cr 343270294269260265206
Depreciation Qtr Cr 17171717161615
Interest Qtr Cr 4454555
Tax Qtr Cr 90708167656849
Net Profit Qtr Cr 266206211199192196152

Abbott India Technicals

EMA & SMA

Current Price
20100.
-82.9 (-0.41%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 19841.46
  • 50 Day
  • 19345.4
  • 100 Day
  • 18998.46
  • 200 Day
  • 18629.04
  • 20 Day
  • 19802.3
  • 50 Day
  • 19082.66
  • 100 Day
  • 19102.57
  • 200 Day
  • 18302.17

Abbott India Resistance and Support

PIVOT
₹20277.64
Resistance
First Resistance 20455.27
Second Resistance 20727.64
Third Resistance 20905.27
RSI 59.8
MFI 71.3
MACD Single Line 334.09
MACD 354.83
Support
First Resistance 20005.27
Second Resistance 19827.64
Third Resistance 19555.27

Abbott India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 9,781 279,052 28.53
Week 10,440 421,969 40.42
1 Month 16,321 596,862 36.57
6 Month 17,289 793,212 45.88

Abbott India Result Highlights

Abbott India Synopsis

NSE-Medical-Diversified

Abbott India Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 4919.27 Cr. and Equity Capital is Rs. 21.25 Cr. for the Year ended 31/03/2022. Abbott India Ltd. is a Public Limited Listed company incorporated on 22/08/1944 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1944PLC007330 and registration number is 007330.
Market Cap 42,710
Sales 5,163
Shares in Float 0.53
No of funds 72
Yield 0.72
Book Value 15.21
U/D Vol ratio 1.1
LTDebt / Equity
Alpha 0.02
Beta 0.47

Abbott India

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 74.99%74.99%74.99%
Mutual Funds 5.67%4.84%4.31%
Insurance Companies 2.04%0.32%0.32%
Foreign Portfolio Investors 0.2%0.2%0.22%
Financial Institutions/ Banks 0.02%0.08%0.32%
Individual Investors 14.6%14.72%15.15%
Others 2.48%4.85%4.69%

Abbott India Management

Name Designation
Mr. Munir Shaikh Chairman
Mr. Vivek V Kamath Managing Director
Mr. Rajiv Sonalker WholeTime Director & CFO
Mr. Kaiyomarz Marfatia Non Executive Director
Mr. Ambati Venu Non Executive Director
Mr. Sabina Ewing Non Executive Director
Mr. Sudarshan Jain Independent Director
Ms. Anisha Motwani Independent Director
Ms. Shalini Kamath Independent Director

Abbott India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Abbott India Corporate Action

Date Purpose Remarks
2022-11-14 Quarterly Results
2022-08-10 Quarterly Results
2022-05-17 Audited Results & Dividend
2022-02-09 Quarterly Results
2021-11-12 Quarterly Results

Abbott India MF Shareholding

Name Amount(cr)
Kotak Equity Arbitrage Fund Growth 22082
Axis Midcap Fund Growth 19708
Canara Robeco Emerging Equities Growth 15581
Nippon India Multi Cap Fund - Growth 14025
ICICI Prudential Equity Arbitrage Fund Regular Growth 10891

Abbott India FAQs

What is Share Price of Abbott India ?

Abbott India share price is ₹20100 As on 05 December, 2022 | 16:14

What is the Market Cap of Abbott India ?

The Market Cap of Abbott India is ₹42711.1 Cr As on 05 December, 2022 | 16:14

What is the P/E ratio of Abbott India ?

The P/E ratio of Abbott India is 48.4 As on 05 December, 2022 | 16:14

What is the PB ratio of Abbott India ?

The PB ratio of Abbott India is 15.1 As on 05 December, 2022 | 16:14

Q2FY23